Market Forecast by Product (assays kits, instruments, and services), by Application (clinical application (early cancer screening, therapy selection, treatment monitoring, recurrence monitoring, and orthopedics), and non-clinical application (oncology (lung cancer, breast cancer, prostate cancer, melanoma cancer, and other cancers) and non-cancer application)), By End User (hospitals, academic & research centers, and others) and by Key Regions (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) and Competitive Landscape
Product Code: ETC037279 | Publication Date: Jul 2022 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 |
Global Liquid Biopsy market report thoroughly covers the market by Product, Technology, End-users, and key regions including the Asia Pacific, Latin America, Middle East, Europe, North America, and Africa. The Global Liquid Biopsy market outlook report provides an unbiased and detailed analysis of the ongoing Global Liquid Biopsy market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Global Liquid Biopsy Market is expected to witness a progression in the coming time zone as a result of a rapid rise in biological science backed by the massive development of the science and technology in the developed and developing economies across the globe has posed a lot of opportunities on the face of the growth and development of biotechnology and life sciences and as a result, is leading to an increase in the growth of the need for Liquid Biopsy drugs and as a result, is expected to pose sound growth prospects for the Global Liquid Biopsy market in the forthcoming years. This is posing bountiful opportunities for the growth of the Liquid Biopsy market and is expected to bring in great growth potential for the key market players in the coming time zone and be benefitted from a strong business growth as a result of an increase in the use of Liquid Biopsy, especially for the treatment of chronic respiratory Products such as asthma and bronchitis. With the increase in the deployment of the product as a result of an increase in the unveiling of the true potential and the benefits which can be reaped by the product deployment, along with the potential health benefits which can be reaped by the injection of the product into the body of the suspect is anticipated to spur the global Liquid Biopsy market in the forthcoming years.
According to 6Wresearch, the Global Liquid Biopsy Market size is anticipated to register growth during 2020-2026. The outbreak of the global pandemic COVID-19 has no doubt, been proven evident in bringing about a revolution in the global Liquid Biopsy market. As the healthcare sector tends to dive into more minimal use tissues as a sampling model to be carried with more agile and technology-driven medical aid, the demand for implementation of liquid biopsy has led to an increase in the deployment of such technological products and has led to increased development of Global Liquid Biopsy Market Growth in this pandemic era. The respiratory sample collected is taken further for the RT-PCR test which brings in real and accurate sample observation. The bringing out of the reports of a covid suspect with the PCR technique has been brought about the best technique with quick and accurate test results. The outbreak has created a threat amongst the population globally and the number of tests has been rapidly increasing. This increase has led to bringing about new horizons for the global Liquid Biopsy Market Growth. As for each new specimen, new equipment is required, the industry makers are receiving bulk orders for the product and as a result, a new revolution and a ladder to success has been offered to the Liquid Biopsy product to make their position in the global market. Since the future is totally unpredictable and sort of such viruses can be faced in the future also, the need and deployment for Liquid Biopsy methods would be deployed at a massive level and this is, no doubt anticipated to benefit the global Liquid Biopsy market to register sound revenue growth in the coming timeframe.
Today, technological advancements in the healthcare sector have led to a feverish speed and as a result have led to an increase in the adoption of technologies that tend to be more agile, quality-driven, and dexterity removal advancements and as a result has led to a rise in the adoption of such technologies. Digital PCR has been proven evident for the calculation and identification of varied pathogenic ailments in a human RNA and DNA solution and has been providing superior results along with assisting the healthcare sector to seek sound growth and development in the field of life sciences and is expected to bring groundbreaking opportunity for digital PCR to maintain performance globally in the coming timeframe. Additionally, not only confined to the hospitals for any testing methods but also an increased use in forensics for accurate DNA replica reports for timely addressed and action to be taken in case of any criminal offense or law-related ailments is expected to bring in new horizons for the growth of the global liquid biopsy market in the next five to ten years.
Increasing consumption of tobacco, and environmental issues are leading to the surge in cancer patients which is further driving the Liquid Biopsy market size. Additionally, according to the WHO, cancer is the leading cause of death. The increasing population coupled with rising awareness regarding the availability of non-invasive treatments is driving the development of the industry.
Several key players operating in the liquid biopsy market are biceps, Gaiden, Neo genomics laboratories, Guardant health, Rain dance technologies, and Personal Genome Diagnostic.
By region, North America is dominating the overall Global Liquid Biopsy Market Growth owing to the accessibility of advanced equipment.
Based on end-user, Reference laboratories accounted for the largest share of the overall Global Liquid Biopsy Market.
The Global Liquid Biopsy Market report provides a detailed analysis of the following market segments:
1. Executive Summary |
2. Introduction |
2.1. Report Description |
2.2. Key Highlights |
2.3. Market Scope & Segmentation |
2.4. Research Methodology |
2.5. Assumptions |
3. Global Liquid Biopsy Market Overview |
3.1. Global Liquid Biopsy Market Revenues, 2016-2026F |
3.2. Global Liquid Biopsy Market Revenue Share, By Product, 2019 & 2026F |
3.3. Global Liquid Biopsy Market Revenue Share, By Application, 2019 & 2026F |
3.4. Global Liquid Biopsy Market Revenue Share, By End User, 2019 & 2026F |
3.5. Global Liquid Biopsy Market Revenue Share, By Regions, 2019 & 2026F |
3.6. Global Liquid Biopsy Market Industry Life Cycle |
3.7. Global Liquid Biopsy Market- Porter’s Five Forces |
4. Global Liquid Biopsy Market Dynamics |
4.1. Impact Analysis |
4.2. Market Drivers |
4.3. Market Restraints |
5. Global Liquid Biopsy Market Trends |
6. Global Liquid Biopsy Market Overview, By Product |
6.1. Global Liquid Biopsy Market Revenues, By Assays Kits, 2016-2026F |
6.2. Global Liquid Biopsy Market Revenues, By Instruments, 2016-2026F |
6.3. Global Liquid Biopsy Market Revenues, By Services, 2016-2026F |
7. Global Liquid Biopsy Market Overview, By Application |
7.1. Global Liquid Biopsy Market Revenues, By Clinical Application, 2016-2026F |
7.1.1. Global Liquid Biopsy Market Revenues, By Early Cancer Screening, 2016-2026F |
7.1.2. Global Liquid Biopsy Market Revenues, By Therapy Selection, 2016-2026F |
7.1.3. Global Liquid Biopsy Market Revenues, By Treatment Monitoring, 2016-2026F |
7.1.4. Global Liquid Biopsy Market Revenues, By Recurrence Monitoring, 2016-2026F |
7.1.5. Global Liquid Biopsy Market Revenues, By Orthopedics, 2016-2026F |
7.2. Global Liquid Biopsy Market Revenues, By Non-clinical Application, 2016-2026F |
7.2.1. Global Liquid Biopsy Market Revenues, By Oncology, 2016-2026F |
7.2.1.1. Global Liquid Biopsy Market Revenues, By Lung Cancer, 2016-2026F |
7.2.1.2. Global Liquid Biopsy Market Revenues, By Breast Cancer, 2016-2026F |
7.2.1.3. Global Liquid Biopsy Market Revenues, By Prostate Cancer, 2016-2026F |
7.2.1.4. Global Liquid Biopsy Market Revenues, By Melanoma Cancer, 2016-2026F |
7.2.1.5. Global Liquid Biopsy Market Revenues, By Other Cancers, 2016-2026F |
7.2.2. Global Liquid Biopsy Market Revenues, By Non-cancer Application, 2016-2026F |
8. Global Liquid Biopsy Market Overview, By End User |
8.1. Global Liquid Biopsy Market Revenues, By Hospitals, 2016-2026F |
8.2. Global Liquid Biopsy Market Revenues, By Academic & Research Centers, 2016-2026F |
8.3. Global Liquid Biopsy Market Revenues, By Others, 2016-2026F |
9. Asia Pacific Liquid Biopsy Market Overview |
9.1. Asia Pacific Liquid Biopsy Market Revenues, 2016-2026F |
9.2. Asia Pacific Liquid Biopsy Market Revenue Share, By Product, 2019 & 2026F |
9.3. Asia Pacific Liquid Biopsy Market Revenue Share, By Application, 2019 & 2026F |
9.4. Asia Pacific Liquid Biopsy Market Revenue Share, By End User, 2019 & 2026F |
9.5. Asia Pacific Liquid Biopsy Market Revenue Share, By Countries, 2019 & 2026F |
10. North America Liquid Biopsy Market Overview |
10.1. North America Liquid Biopsy Market Revenues, 2016-2026F |
10.2. North America Liquid Biopsy Market Revenue Share, By Product, 2019 & 2026F |
10.3. North America Liquid Biopsy Market Revenue Share, By Application, 2019 & 2026F |
10.4. North America Liquid Biopsy Market Revenue Share, By End User, 2019 & 2026F |
10.5. North America Liquid Biopsy Market Revenue Share, By Countries, 2019 & 2026F |
11. Latin America Liquid Biopsy Market Overview |
11.1. Latin America Liquid Biopsy Market Revenues, 2016-2026F |
11.2. Latin America Liquid Biopsy Market Revenue Share, By Product, 2019 & 2026F |
11.3. Latin America Liquid Biopsy Market Revenue Share, By Application, 2019 & 2026F |
11.4. Latin America Liquid Biopsy Market Revenue Share, By End User, 2019 & 2026F |
11.5. Latin America Liquid Biopsy Market Revenue Share, By Countries, 2019 & 2026F |
12. Europe Liquid Biopsy Market Overview |
12.1. Europe Liquid Biopsy Market Revenues, 2016-2026F |
12.2. Europe Liquid Biopsy Market Revenue Share, By Product, 2019 & 2026F |
12.3. Europe Liquid Biopsy Market Revenue Share, By Application, 2019 & 2026F |
12.4. Europe Liquid Biopsy Market Revenue Share, By End User, 2019 & 2026F |
12.5. Europe Liquid Biopsy Market Revenue Share, By Countries, 2019 & 2026F |
13. Middle East Liquid Biopsy Market Overview |
13.1. Middle East Liquid Biopsy Market Revenues, 2016-2026F |
13.2. Middle East Liquid Biopsy Market Revenue Share, By Product, 2019 & 2026F |
13.3. Middle East Liquid Biopsy Market Revenue Share, By Application, 2019 & 2026F |
13.4. Middle East Liquid Biopsy Market Revenue Share, By End User, 2019 & 2026F |
13.5. Middle East Liquid Biopsy Market Revenue Share, By Countries, 2019 & 2026F |
14. Africa Liquid Biopsy Market Overview |
14.1. Africa Liquid Biopsy Market Revenues, 2016-2026F |
14.2. Africa Liquid Biopsy Market Revenue Share, By Product, 2019 & 2026F |
14.3. Africa Liquid Biopsy Market Revenue Share, By Application, 2019 & 2026F |
14.4. Africa Liquid Biopsy Market Revenue Share, By End User, 2019 & 2026F |
14.5. Africa Liquid Biopsy Market Revenue Share, By Countries, 2019 & 2026F |
15. Global Liquid Biopsy Market Competitive Landscape |
15.1. Global Liquid Biopsy Market, By Companies, 2019 |
15.2. Asia Pacific Liquid Biopsy Market, By Companies, 2019 |
15.3. North America Liquid Biopsy Market, By Companies, 2019 |
15.4. Latin America Liquid Biopsy Market, By Companies, 2019 |
15.5. Europe Liquid Biopsy Market, By Companies, 2019 |
15.7. Middle East Liquid Biopsy Market, By Companies, 2019 |
15.8. Africa Liquid Biopsy Market, By Companies, 2019 |
16. Company Profiles |
17. Key Strategic Recommendations |